Gen-Biotec Profile
Key Indicators
- Authorised Capital ₹ 1.40 M
- Paid Up Capital ₹ 1.40 M
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 14.36%
- Profit Growth -130.04%
- Ebitda -53.86%
- Net Worth 15.88%
- Total Assets -19.69%
About Gen-Biotec
Gen-Biotec Private Limited (GPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 June 2000 and has a history of 24 years and seven months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.40 M and a paid-up capital of Rs 1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Veetath Madhusudhan, Kammana Prasad, and Kizhakke Kumar serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111TN2000PTC045201
-
Company No.
045201
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jun 2000
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Gen-Biotec?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veetath Madhusudhan
|
Managing Director | 01-Mar-2006 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kammana Prasad
|
Director | 03-Jan-2011 | Current |
|
Kizhakke Kumar
|
Director | 16-Aug-2016 | Current |
Financial Performance of Gen-Biotec.
Gen-Biotec Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.36% increase. The company also saw a substantial fall in profitability, with a 130.04% decrease in profit. The company's net worth Soared by an impressive increase of 15.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gen-Biotec?
In 2023, Gen-Biotec had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gen-Biotec?
Unlock and access historical data on people associated with Gen-Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gen-Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gen-Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
